Rotator Cuff Injury Treatment Market by Modality (Surgical (Arthroscopy, Shoulder Replacement, Tendon Repair), Physiotherapy (Braces, Cold Compression), Drug Therapeutics (Anti-inflammatory Drugs, Injections), Orthobiologics) -Global Forecast to 2026

ローテーターカフ損傷治療の世界市場予測(~2026):モダリティ別

◆タイトル:Rotator Cuff Injury Treatment Market by Modality (Surgical (Arthroscopy, Shoulder Replacement, Tendon Repair), Physiotherapy (Braces, Cold Compression), Drug Therapeutics (Anti-inflammatory Drugs, Injections), Orthobiologics) -Global Forecast to 2026
◆商品コード:MD8076-22
◆調査・発行会社:MarketsandMarkets
◆発行日:2022年4月12日
◆ページ数:117
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥0見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥0見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥0見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

マーケッツアンドマーケッツ社は、世界のローテーターカフ損傷治療市場規模が2021年989百万ドルから2026年1,244百万ドルまで、年平均4.7%成長すると予想しています。本市場調査資料では、ローテーターカフ損傷治療の世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場概要、種類別(手術/治癒的治療、理学療法/緩和治療、医薬品/予防的治療、整形手術)分析、地域別分析、競争状況、企業情報などの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場概要
・世界のローテーターカフ損傷治療市場規模:種類別(手術/治癒的治療、理学療法/緩和治療、医薬品/予防的治療、整形手術)
・世界のローテーターカフ損傷治療市場規模:地域別
・競争状況
・企業情報

“The global rotator cuff injury treatment market is projected to reach USD 1,244 million by 2026 from USD 989 million in 2021, at a CAGR of 4.7% during the forecast period.”
The key factors fueling the growth of this market include an increase in sports related shoulder injuries, technological advancements in arthroscopic surgical devices, increase in the aging population with osteoarthritis, strong focus of players towards launch of highly advanced arthroscopic treatment devices. On the other hand, a dearth of skilled professionals, a high surgical treatment failure rate, and its high cost are major challenges faced by market players providing rotator cuff injury treatment products.

The COVID-19 pandemic is an unprecedented crisis that has significantly strained healthcare providers, healthcare infrastructure, and healthcare systems worldwide. The COVID-19 pandemic had a remarkable change in several aspects of medical practice. Elective surgeries, including orthopedic surgery, were canceled worldwide, allowing hospitals to accommodate more COVID-19 patients and completely focus on reducing the possible risk of infection among healthcare workers. According to The CovidSurg Collaborative, a 120-country research initiative formed to analyze the impact of the COVID-19 pandemic on surgeries, around 28.4 million elective surgeries worldwide will be canceled or postponed in 2020, based on 12 weeks of peak disruption to hospital services due to COVID-19. The rotator cuff injury treatment market was also impacted due to restrictions on the organized temporary closure of surgical centers, hospital access restriction for non-essential care, limited access to clinics, implementation of social distancing measures, nationwide lockdowns, and the slowdown of in-patient flow and referrals.

“The surgical or curative treatment to capture the largest share in rotator cuff injury treatment market, by type during the forecast period.”
The surgical treatment segment is expected to hold the largest share of rotator cuff injury treatment market, during the forecast period. This is attributable to the high adoption due to the increasing prevalence of rotator cuff injuries majorly among sportspersons, rising awareness activities by major market players across key countries, and the availability of medical reimbursements for surgical treatment of rotator cuff rupture. Additionally, the increase in the preference of shoulder arthroscopy for the treatment rotator cuff tear among surgeons and the growing awareness about the benefits associated with arothrocopic repair such as lower risk of complications, quick recovery, low rate of post surgical infections are likely to play a significant role in propelling the growth of the segment.

“The Asia Pacific market to grow at the highest CAGR during the forecast period.”
The rotator cuff injury treatment market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. significant increase in its geriatric and patient population for orthopedic diseases, growing adoption of orthopedic bracing products in developing nations of Asia Pacific, growing presence of rotator cuff injury treatment devices and drugs manufacturers in the country, increase in the initiatives by the government to promote sports, and growing adoption of new surgical devices for rotator cuff tears launched by local manufacturers are likely to support the growth of the market in the region.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1: 25%, Tier 2: 30%, and Tier 3: 45%
• By Designation: C-level: 26%, D-level: 30%, and Others: 44%
• By Region: North America: 40%, Europe: 31%, APAC: 20%, Latin America: 6%, and the Middle East & Africa: 3%

Arthrex (US), Stryker Corporation (US), Smith & Nephew (UK), Johnson & Johnson (DePuy Synthes) (US), Zimmer Biomet (US), CONMED Corporation (US), Integra LifeSciences Corporation (US), LimaCorporate (Italy), FH ORTHOPEDICS S.A.S. (France), Evolutis India Pvt Ltd. (India), DJO Global (US), 3S Ortho (France), Breg, Inc. (US), GPC Medical Ltd. (India), and Parcus Medical (US).

Research Coverage
This report studies the global rotator cuff injury treatment market based on the treatment type, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the global in rotator cuff injury treatment market, and high-growth regions and their drivers, restraints, opportunities, and challenges. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

【レポートの目次】

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 15
1.3 MARKET SCOPE 15
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY USED FOR THE STUDY 16
1.5 MAJOR MARKET STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 RESEARCH DATA 17
FIGURE 1 RESEARCH DESIGN 17
2.1.1 SECONDARY DATA SOURCES 18
2.1.1.1 Secondary Data Sources 19
2.1.2 PRIMARY DATA SOURCES 20
FIGURE 2 BREAKDOWN OF PRIMARIES: ROTATOR CUFF RUPTURE TREATMENT MARKET 20
2.2 MARKET ESTIMATION METHODOLOGY 20
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 21
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 21
2.2.2 TREATMENT USAGE-BASED MARKET ESTIMATION 22
FIGURE 4 MARKET SIZE ESTIMATION BASED ON TREATMENT UTILIZATION METHODOLOGY 22
FIGURE 5 MARKET SIZE ESTIMATION BASED ON REVENUE MAPPING METHODOLOGY 23
2.2.3 PRIMARY RESEARCH VALIDATION 23
2.3 DATA TRIANGULATION 24
FIGURE 6 DATA TRIANGULATION METHODOLOGY 24
2.4 RESEARCH ASSUMPTIONS 25
2.5 RESEARCH LIMITATIONS 25
3 EXECUTIVE SUMMARY 26
3.1 ROTATOR CUFF RUPTURE TREATMENT MARKET 26
FIGURE 7 ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 26
FIGURE 8 MARKET OPPORTUNITY IN ROTATOR CUFF RUPTURE TREATMENT MARKET DURING 2020-2026 (USD MN) 27
4 MARKET OVERVIEW 28
4.1 INTRODUCTION 28
4.2 MARKET DYNAMICS 28
4.2.1 INDUSTRY GROWTH OPPORTUNITIES 28
4.2.1.1 Rising number of sports-related shoulder injuries 28
FIGURE 9 INJURIES CAUSED BY VARIOUS SPORTS ACTIVITIES IN THE US PER 1000 INHABITANATS (2020) 29
4.2.1.2 Technological advancements in rotator cuff rupture devices 30
4.2.1.3 Growing public-private funding grants and educational awareness initiatives 30
4.2.1.4 Increasing risk of osteoarthritis in the geriatric population 31
TABLE 1 NUMBER OF PERSONS AGED 65 YEARS OR OVER BY GEOGRAPHIC REGION (2019 VS. 2050) 32
4.2.1.5 Growing developments in orthobiologics 32
4.2.2 BURNING ISSUES AND CHALLENGES 33
4.2.2.1 High costs associated with arthroscopic surgical procedures 33
4.2.2.2 High failure rates of rotator cuff surgical treatment 33
4.2.2.3 Shortage of trained orthopedic professionals 33
4.2.3 COVID-19 SPECIFIC TRENDS 34
4.3 REGULATORY LANDSCAPE 34
4.3.1 NORTH AMERICA 34
4.3.1.1 US 34
TABLE 2 US FDA: MEDICAL DEVICE CLASSIFICATION 35
TABLE 3 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 35
4.3.1.2 Canada 36
TABLE 4 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 36
FIGURE 10 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (CMDR) 37
4.3.2 EUROPE 37
FIGURE 11 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR) 39
4.3.3 ASIA PACIFIC 39
4.3.3.1 India 39
4.3.3.2 Japan 39
TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 40
4.3.3.3 China 40
TABLE 6 CHINA: CLASSIFICATION OF MEDICAL DEVICES 40
4.3.3.4 India 41
4.4 REIMBURSEMENT SCENARIO 42
TABLE 7 REIMBURSEMENT CODES FOR PHYSICIAN SERVICES (AS OF 2020) 42
TABLE 8 REIMBURSEMENT CODES FOR OUTPATIENT SERVICES (AS OF 2020) 42
4.5 PRICING TREND ANALYSIS 43
TABLE 9 AVERAGE PRICE OF ROTATOR CUFF TREATMENT INSTRUMENTS, BY REGION COUNTRY, 2020 (USD) 43
4.6 CLINICAL RESEARCH PIPELINE 44
4.6.1 ROTATOR CUFF REPAIR TREATMENT 44
TABLE 10 ROTATOR CUFF REPAIR: INDICATIVE LIST OF ONGOING CLINICAL TRIALS
(AS OF 2021) 44
4.7 PATENT ANALYSIS 49
FIGURE 12 TOP 10 PATENT APPLICANTS FOR ROTATOR CUFF REPAIR
(JANUARY 2011 TO OCTOBER 2021) 49
FIGURE 13 NUMBER OF GRANTED PATENTS AND PATENT APPLICATIONS
(JANUARY 2011 TO OCTOBER 2021) 50
FIGURE 14 PATENT DOCUMENTS FOR ROTATOR CUFF REPAIR, BY LEGAL STATUS (JANUARY 2011 TO OCTOBER 2021) 50
FIGURE 15 REGIONAL ANALYSIS OF PATENTS GRANTED FOR ROTATOR CUFF REPAIR, 2020 50
5 ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE 51
5.1 INTRODUCTION 52
TABLE 11 ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
5.2 SURGICAL OR CURATIVE TREATMENT 52
5.2.1 TRADITIONAL/OPEN SURGERIES 52
5.2.1.1 Shoulder replacement surgeries 53
5.2.1.2 Open tendon repair/transfer 53
5.2.2 ARTHROSCOPY (TENDON REPAIR) 53
TABLE 12 ARTHOSCOPY TREATMENT MARKET, BY REGION, 2019–2026 (USD MILLION) 54
5.3 PHYSIOTHERAPY OR PALLIATIVE TREATMENT 54
TABLE 13 PHYSIOTHERAPY TREATMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 54
5.3.1 ORTHOPEDIC BRACES 55
TABLE 14 ORTHOPEDIC BRACES MARKET, BY REGION, 2019–2026 (USD MILLION) 55
5.3.2 COLD COMPRESSION THERAPY 55
TABLE 15 COLD COMPRESSION THERAPY MARKET, BY REGION,
2019–2026 (USD MILLION) 56
5.4 PHARMACEUTICAL DRUGS OR PREVENTIVE TREATMENT 56
TABLE 16 PHARMACEUTICAL DRUGS MARKET, BY TYPE, 2019–2026 (USD MILLION) 56
5.4.1 ANTI-INFLAMMATORY DRUGS AND PAIN KILLERS 57
TABLE 17 ANTI-INFLAMMATORY DRUGS AND PAIN KILLERS MARKET,
2019–2026 (USD MILLION) 57
5.4.2 INJECTIONS 57
TABLE 18 INJECTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 58
5.5 ORTHOBIOLOGICS 58
TABLE 19 ORTHOBIOLOGICS MARKET, BY TYPE, 2019–2026 (USD MILLION) 58
6 ROTATOR CUFF RUPTURE TREATMENT MARKET, BY REGION 59
6.1 INTRODUCTION 59
TABLE 20 ROTATOR CUFF RUPTURE TREATMENT MARKET, BY REGION,
2019–2026 (USD MILLION) 59
6.2 NORTH AMERICA 59
TABLE 21 NORTH AMERICA ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 60
6.3 EUROPE 61
TABLE 22 EUROPE ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 61
6.4 ASIA PACIFIC 62
TABLE 23 ASIA PACIFIC ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 63
6.5 LATIN AMERICA 63
TABLE 24 LATIN AMERICA ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 64
6.6 MIDDLE EAST & AFRICA 64
TABLE 25 MIDDLE EAST & AFRICA ROTATOR CUFF RUPTURE TREATMENT MARKET,
BY TYPE, 2019–2026 (USD MILLION) 64
7 COMPETITIVE LANDSCAPE 65
7.1 OVERVIEW 65
7.1.1 KEY PLAYER STRATEGIES 65
7.2 LIST OF KEY PLAYERS OPERATING IN EACH TREATMENT SPACE 66
7.2.1 PRODUCT PORTFOLIO/DEVELOPMENT PIPELINE 67
7.2.2 KEY STRATEGIES/RIGHT TO WIN 69
7.3 COMPETITIVE SCENARIO 71
7.3.1 ROTATOR CUFF RUPTURE TREATMENT MARKET: PRODUCT LAUNCHES & REGULATORY APPROVALS 71
TABLE 26 KEY PRODUCT LAUNCHES & REGULATORY APPROVALS,
JANUARY 2018–OCTOBER 2021 71
7.3.2 ROTATOR CUFF RUPTURE TREATMENT MARKET: DEALS 71
TABLE 27 KEY DEALS, JANUARY 2018–OCTOBER 2021 71
7.3.3 ROTATOR CUFF RUPTURE TREATMENT MARKET: OTHER DEVELOPMENTS 72
TABLE 28 OTHER KEY DEVELOPMENTS, JANUARY 2018–OCTOBER 2021 72
7.3.4 COMPETITIVE LEADERSHIP MAPPING 72
7.3.4.1 Stars 72
7.3.4.2 Pervasive players 73
7.3.4.3 Emerging leaders 73
7.3.4.4 Participants 73
FIGURE 16 ROTATOR CUFF RUPTURE TREATMENT MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020 73
7.4 FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ROTATOR CUFF RUPTURE TREATMENT MARKET 74
7.4.1 TREATMENT PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ROTATOR CUFF RUPTURE TREATMENT MARKET 74
TABLE 29 TREATMENT PRODUCT FOOTPRINT OF COMPANIES 74
TABLE 30 REGIONAL FOOTPRINT OF COMPANIES 75
8 COMPANY PROFILES 76
8.1 KEY PLAYERS 76
(Business overview, Products offered, Recent developments, and MnM view)*
8.1.1 STRYKER CORPORATION 76
TABLE 31 STRYKER CORPORATION: BUSINESS OVERVIEW 76
FIGURE 17 STRYKER CORPORATION: COMPANY SNAPSHOT (2020) 77
8.1.2 JOHNSON & JOHNSON 80
TABLE 32 JOHNSON & JOHNSON: BUSINESS OVERVIEW 80
FIGURE 18 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2020) 81
8.1.3 SMITH & NEPHEW 83
TABLE 33 SMITH & NEPHEW: BUSINESS OVERVIEW 83
FIGURE 19 SMITH & NEPHEW: COMPANY SNAPSHOT (2020) 84
8.1.4 ARTHREX 87
TABLE 34 ARTHREX: BUSINESS OVERVIEW 87
8.1.5 ZIMMER BIOMET 89
TABLE 35 ZIMMER BIOMET: BUSINESS OVERVIEW 89
FIGURE 20 ZIMMER BIOMET: COMPANY SNAPSHOT (2020) 90
8.1.6 INTEGRA LIFESCIENCES 92
TABLE 36 INTEGRA LIFESCIENCES: BUSINESS OVERVIEW 92
FIGURE 21 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2020) 93
8.1.7 LIMACORPORATE S.P.A 94
TABLE 37 LIMACORPORATE: BUSINESS OVERVIEW 94
FIGURE 22 LIMACORPORATE: COMPANY SNAPSHOT (2020) 94
8.1.8 DJO GLOBAL, INC. 96
TABLE 38 DJO GLOBAL, INC.: BUSINESS OVERVIEW 96
FIGURE 23 DJO GLOBAL, INC.: COMPANY SNAPSHOT (2020) 97
8.1.9 EVOLUTIS 99
TABLE 39 EVOLUTIS: BUSINESS OVERVIEW 99
8.1.10 GROUP FH ORTHO 100
TABLE 40 GROUP FH ORTHO: BUSINESS OVERVIEW 100
8.1.11 CONMED CORPORATION 102
TABLE 41 CONMED CORPORATION: BUSINESS OVERVIEW 102
FIGURE 24 CONMED CORPORATION: COMPANY SNAPSHOT (2020) 103
8.1.12 3S ORTHO 105
TABLE 42 3S ORTHO: BUSINESS OVERVIEW 105
8.1.13 ANIKA THERAPEUTICS, INC. (PARCUS MEDICAL) 106
TABLE 43 ANIKA THERAPEUTICS: BUSINESS OVERVIEW 106
FIGURE 25 ANIKA THERAPEUTICS, INC.: COMPANY SNAPSHOT (2020) 107
8.1.14 GPC MEDICAL LTD. 109
TABLE 44 GPC MEDICAL LTD.: BUSINESS OVERVIEW 109
8.1.15 BREG, INC. 110
TABLE 45 BREG, INC.: BUSINESS OVERVIEW 110
*Details on Business overview, Products offered, Recent developments, and MnM view not be captured in case of unlisted companies.
9 APPENDIX 112
9.1 DISCUSSION GUIDE 112
9.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 115
9.3 RELATED REPORTS 117
9.4 AVAILABLE CUSTOMIZATIONS 118



★調査レポート[ローテーターカフ損傷治療の世界市場予測(~2026):モダリティ別] ( Rotator Cuff Injury Treatment Market by Modality (Surgical (Arthroscopy, Shoulder Replacement, Tendon Repair), Physiotherapy (Braces, Cold Compression), Drug Therapeutics (Anti-inflammatory Drugs, Injections), Orthobiologics) -Global Forecast to 2026 / MD8076-22) 販売に関する免責事項
[ローテーターカフ損傷治療の世界市場予測(~2026):モダリティ別] ( Rotator Cuff Injury Treatment Market by Modality (Surgical (Arthroscopy, Shoulder Replacement, Tendon Repair), Physiotherapy (Braces, Cold Compression), Drug Therapeutics (Anti-inflammatory Drugs, Injections), Orthobiologics) -Global Forecast to 2026 / MD8076-22) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆